Clinical Trial Update: Anti-TGF-beta Therapy in Patients With Myelofibrosis [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating an anti-TGF-beta therapy in myelofibrosis was terminated; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Thrombocythemia
• Myelofibrosis
• Polycythemia Vera

Drugs mentioned

• Anti-TGF-beta therapy

Snippet

Sponsor: John Mascarenhas | Conditions: Myelofibrosis, Primary Myelofibrosis | Phase 1 | Status: TERMINATED | Results posted: 2014-08-28